Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2005 • 18,835 citations

The 2007 WHO Classification of Tumours of the Central Nervous System

2007 • 13,561 citations

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2009 • 7,014 citations

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

2010 • 6,768 citations

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

2006 • 5,923 citations

WHO classification of tumours of the central nervous system

2007 • 3,749 citations

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

2006 • 3,007 citations

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

2003 • 952 citations

Gene Expression Profiling of Gliomas Strongly Predicts Survival

2004 • 732 citations

FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme

2009 • 580 citations

Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

2005 • 534 citations

Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma

2004 • 528 citations

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

2001 • 501 citations

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

2006 • 494 citations

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001

2006 • 336 citations

Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial

2005 • 308 citations

Gene expression profiling identifies molecular subtypes of gliomas

2003 • 308 citations

Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients

2008 • 286 citations

Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence

2009 • 283 citations

Identification of molecular subtypes of glioblastoma by gene expression profiling

2003 • 275 citations

Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination

2004 • 267 citations

Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme

2008 • 263 citations

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

2003 • 257 citations

Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes

2009 • 215 citations

The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity

2006 • 205 citations

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

2008 • 204 citations

Vaccination of Glioma Patients with Fusions of Dendritic and Glioma Cells and Recombinant Human Interleukin 12

2004 • 204 citations

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

2007 • 191 citations

Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability

2008 • 182 citations

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival

2010 • 162 citations

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

2007 • 128 citations

Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue

1981 • 84 citations

Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex—bound immunogenic peptides induced by interferon-α and interferon-γ treatment of human glioblastoma multiforme

2004 • 82 citations

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy

2007 • 81 citations

Antigen loading of dendritic cells with whole tumor cell preparations

2003 • 78 citations

Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis

2007 • 75 citations

Celsius: a community resource for Affymetrix microarray data

2007 • 63 citations

Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications

2006 • 29 citations

Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology

2006 • 7 citations